TBPH
Price:
$18.7
Market Cap:
$947.59M
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also include Izencitinib, a gut-selective pan-janus kinase (JAK) inhibitor that is in Phase IIb/III clinical trials for the treatment of rheumatoid arthritis, myelofibrosis, and ulcerative colitis, as well as for a range of inflammatory intestinal diseases, including ulcerative colitis and Crohn's disease. In addition, the company's product portfolio comprise...[Read more]
Industry
Biotechnology
IPO Date
2014-05-16
Stock Exchange
NASDAQ
Ticker
TBPH
According to Theravance Biopharma, Inc.’s latest financial reports and current stock price. The company's current ROE is 8.18%. This represents a change of 883.85% compared to the average of 0.83% of the last 4 quarters.
The mean historical ROE of Theravance Biopharma, Inc. over the last ten years is 43.60%. The current 8.18% ROE has changed -81.24% with respect to the historical average. Over the past ten years (40 quarters), TBPH's ROE was at its highest in in the September 2018 quarter at 442.05%. The ROE was at its lowest in in the June 2018 quarter at -118.70%.
Average
43.60%
Median
16.49%
Minimum
-247.79%
Maximum
417.77%
Discovering the peaks and valleys of Theravance Biopharma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 355.16%
Maximum Annual ROE = 417.77%
Minimum Annual Increase = -268.60%
Minimum Annual ROE = -247.79%
| Year | ROE | Change |
|---|---|---|
| 2024 | -32.14% | 24.03% |
| 2023 | -25.91% | -113.13% |
| 2022 | 197.40% | 235.14% |
| 2021 | 58.90% | -35.65% |
| 2020 | 91.53% | -13.36% |
| 2019 | 105.64% | -74.71% |
| 2018 | 417.77% | -268.60% |
| 2017 | -247.79% | 355.16% |
| 2016 | -54.44% | -27.38% |
| 2015 | -74.97% | -8.35% |
The current ROE of Theravance Biopharma, Inc. (TBPH) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
46.45%
5-year avg
57.96%
10-year avg
43.60%
Theravance Biopharma, Inc.’s ROE is less than BlackRock Technology and Private Equity Term Trust (1.87%), less than Monte Rosa Therapeutics, Inc. (9.95%), greater than Day One Biopharmaceuticals, Inc. (-32.05%), greater than Geron Corporation (-30.28%), greater than Replimune Group, Inc. (-69.34%), greater than Vir Biotechnology, Inc. (-50.22%), greater than LENZ Therapeutics, Inc. (-25.63%), greater than ArriVent BioPharma, Inc. Common Stock (-55.48%), greater than Valneva SE (-35.27%), greater than Tyra Biosciences, Inc. (-31.80%),
| Company | ROE | Market cap |
|---|---|---|
| 1.87% | $786.63M | |
| 9.95% | $1.12B | |
| -32.05% | $856.31M | |
| -30.28% | $810.71M | |
| -69.34% | $825.97M | |
| -50.22% | $943.19M | |
| -25.63% | $778.71M | |
| -55.48% | $1.01B | |
| -35.27% | $742.49M | |
| -31.80% | $1.18B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Theravance Biopharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Theravance Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Theravance Biopharma, Inc.'s ROE?
How is the ROE calculated for Theravance Biopharma, Inc. (TBPH)?
What is the highest ROE for Theravance Biopharma, Inc. (TBPH)?
What is the 3-year average ROE for Theravance Biopharma, Inc. (TBPH)?
What is the 5-year average ROE for Theravance Biopharma, Inc. (TBPH)?
How does the current ROE for Theravance Biopharma, Inc. (TBPH) compare to its historical average?